October 2024
1. OHAEGBULAM KC, Post CM, Farris PE, Garzotto M, et al
   Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.
   Am J Clin Oncol. 2024 Oct 30. doi: 10.1097/COC.0000000000001151.
   

   >> Share

   
   September 2024
2. RITTER AR, Prasad RN, Jhawar SR, Bazan JG, et al
   Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation Oncologists.
   Am J Clin Oncol. 2024;47:434-438.
   

   >> Share

   
   August 2024
3. MELLGARD G, Saffran N, Chakrani Z, McCroskery S, et al
   Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted Therapy.
   Am J Clin Oncol. 2024 Aug 1. doi: 10.1097/COC.0000000000001115.
   

   >> Share

   
   July 2024
4. LEHRER S, Rheinstein PH
   Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer.
   Am J Clin Oncol. 2024 Jul 8. doi: 10.1097/COC.0000000000001134.
   

   >> Share

   
   February 2024
5. CHAKRANI Z, Mellgard G, Saffran N, McCroskery S, et al
   Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy.
   Am J Clin Oncol. 2024 Feb 12. doi: 10.1097/COC.0000000000001087.
   

   >> Share

   
   January 2024
6. JANOPAUL-NAYLOR JR, Koo A, Qian DC, McCall NS, et al
   Physician Assessment of ChatGPT and Bing Answers to American Cancer Society's Questions to Ask About Your Cancer.
   Am J Clin Oncol. 2024;47:17-21.
   

   >> Share

   
   May 2023
7. CAO Z, Yao J, He Y, Lou D, et al
   Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer: A Meta-analysis Based on Observational Studies.
   Am J Clin Oncol. 2023 May 5. doi: 10.1097/COC.0000000000001012.
   

   >> Share

   
   June 2022
8. BITTNER NHJ, Cox BW, Davis B, King M, et al
   ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer.
   Am J Clin Oncol. 2022;45:249-257.
   

   >> Share

   
   May 2022
9. POST CM, Kahn JM, Turina CB, Beer TM, et al
   Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer: Benefit or Caution?
   Am J Clin Oncol. 2022;45:190-195.
   

   >> Share

   
   January 2022
10. ROVIELLO G, Nardone V, Bonetta A, Correale P, et al
    Effects of Whole Pelvic Radiotherapy on the Distribution of Lymphocyte Subpopulations in Prostate Cancer Patients.
    Am J Clin Oncol. 2022 Jan 26. pii: 00000421-900000000-98506.
    

    >> Share

    
    October 2021
11. VIANI GA, Gouveia AG, Jacinto AA, Moraes FY, et al
    Stereotactic Body Radiotherapy for Prostate Cancer: Where, When, and Who? A Bibliometric Analysis.
    Am J Clin Oncol. 2021 Oct 6. pii: 00000421-900000000-98529.
    

    >> Share

    
    June 2021
12. MERRICK GS, Galbreath R, Fiano R, Scholl W, et al
    The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients.
    Am J Clin Oncol. 2021 Jun 7. pii: 00000421-900000000-98553.
    

    >> Share

    
    May 2021
13. SOLIMAN L, De Souza A, Srinivasan P, Danish M, et al
    The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies.
    Am J Clin Oncol. 2021 May 17. pii: 00000421-900000000-98561.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share